Green light for new medicines
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.
by Bruce Sylvester: Menopausal women having difficulty with time management, attention, organization, memory, and problem solving (also known as “executive functions”) appear to benefit from treatment with lisdexamfetamine,… read more.
by Bruce Sylvester: Rociletinib, an investigative therapy for treatment resistant EGFR-mutation driven lung tumors, shows activity against the most common resistance mutation, and it significantly improves clinical outcomes.
by Gary Finnegan: Keytruda (pembrolizumab) has been recommended by the European Medicines Agency (EMA) as monotherapy for the treatment of adult patients with advanced melanoma that cannot be… read more.
by Gary Finnegan: Patients whose high cholesterol cannot be controlled by currently available therapies are set to have a new treatment option.
by Gary Finnegan: Survival rates in young patients with high-risk neuroblastoma can be improved by Unituxin (dinutuximab), a new treatment approved by the European Medicines Agency (EMA).
Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint. For the first time, this new fingerprint method… read more.
by Gary Finnegan: Canada could save $7.3 billion annually with universal public coverage of medically necessary prescription drugs, according to new research from the University of British Columbia… read more.
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: The European Medicines Agency (EMA) has reduced the fees it charges to companies who hold – or apply for – marketing authorisation for medicines.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.